Levocetirizin Krka

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizin Krka, is a second‑generation antihistamine presented as a tablet for oral use. It alleviates histamine‑mediated symptoms such as sneezing, nasal congestion, itching and hives in patients with allergic rhinitis or chronic idiopathic urticaria.

GNH USA supplies Levocetirizin Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers. Its global distribution network ensures reliable delivery to diverse healthcare settings.

Levocetirizine Dihydrochloride is used to manage allergic conditions by blocking peripheral H1 receptors. - Allergic rhinitis (seasonal or perennial): reduces nasal congestion, sneezing, itching and rhinorrhea. - Chronic idiopathic urticaria: decreases frequency and severity of hives and associated itching. - Allergic conjunctivitis: alleviates eye itching, redness and watery discharge.

Levocetirizin Krka is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Drowsiness: mild to moderate sleepiness, especially at treatment initiation. - Headache: transient tension‑type headache. - Dry mouth: reduced salivation causing mild discomfort. - Fatigue: feeling of reduced energy.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat requiring urgent care. - Severe skin rash (e.g., Stevens‑Johnson syndrome): extensive blistering and detachment of skin. - Anaphylactic reaction: sudden systemic hypersensitivity with respiratory compromise.

Levocetirizin Krka should be used with awareness of specific safety considerations. - Pregnancy: consult a healthcare professional as safety data are limited. - Breastfeeding: caution advised; the drug may be excreted in breast milk. - Renal impairment: use with caution; dose adjustment may be required in severe dysfunction. - Elderly patients: monitor for increased sedation or dizziness. - Avoid alcohol: concurrent intake may potentiate drowsiness. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and light.

Levocetirizin Krka may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise levocetirizine plasma concentrations. - Alcohol or other central nervous system depressants: may enhance sedative effects.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may increase dry‑mouth sensation. - Theophylline: may reduce antihistamine efficacy. - Ritonavir: may modestly increase levocetirizine levels, requiring observation.